Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, Retatrutide https://prestonklum207873.luwebs.com/36905973/setmelanotide-a-promising-new-treatment-for-obesity